Inhibition of hepatocelluar carcinoma MAT2A and MAT2beta gene expressions by single and dual small interfering RNA

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Wang, Qun ^a   Liu, Quan Yan ^a   Liu, Zhi Su ^a   Qian, Qun ^a   Sun, Quan ^a   Pan, Ding Yu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; METHIONINE ADENOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA; MAT2A PROTEIN, HUMAN; MAT2BETA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN HEPG2; ENZYME ACTIVE SITE; ENZYME SUBUNIT; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RNA INTERFERENCE; TUMOR GENE; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; METHIONINE ADENOSYLTRANSFERASE; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 58149293300     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-72     Document Type: Article

References (44)

1. Expression and functional interaction of the catalytic and regulatory subunits of human methionine adenosyltransferase in mammalian cells. AB Halim L LeGros A Geller M Kotb, J Biol Chem 1999 274 29720 29725 10.1074/jbc.274.42. 29720 10514445
2. Spontaneous oxidativestress and livertumors in mice lacking methionine adenosyltransferase 1A. ML Martínez-Chantar FJ Corrales LA Martínez-Cruz ER García-Trevijano ZZ Huang L Chen G Kanel MA Avila JM Mato SC Lu, FASEB J 2002 16 1292 1294 12060674
3. S-Adenosylmethionine: a control switch that regulates liver function. JM Mato FJ Corrales SC Lu MA Avila, FASEB J 2002 16 15 26 10.1096/fj.01-0401rev 11772932
4. Methionine Adenosyltransferase IIβ Subunit Gene Expression Provides a Proliferative Advantage in Human Hepatoma. ML Martínez-Chantar ER García-Trevijano MU Latasa A Martín-Duce P Fortes J Caballería MA Avila JM Mato, GASTROENTEROLOGY 2003 124 940 948 10.1053/gast.2003.50151 12671891
5. Effect of Hepatocyte Growth Factor on Methionine Adenosyltransferase Genes and Growth Is Cell Density-Dependent in HepG2 Cells. H Yang N Magilnick M Noureddin JM Mato SC Lu, JOURNAL OF CELLULAR PHYSIOLOGY 2007 210 766 773 10.1002/jcp.20891 17154373
6. Lu Leptin's Mitogenic Effect in Human Liver Cancer Cells Requires Induction of Both Methionine Adenosyltransferase 2A and 2β K Ramani H Yang M Xia AI Ara JM Mato SC Lu, Hepatology 2008 47 2 521 531 18041713 10.1002/hep.22064
7. Silencing MAT2A gene by RNA interference inhibited cell growth and induced apoptosis in human hepatoma cells. Q Liu K Wu Y Zhu Y He J Wu Z Liu, Hepatology Research 2007 37 376 388 10.1111/j.1872-034X.2007.00041.x 17441811
8. VRX-496(VIRxSYS). KV Morris, Curr Opin Investig Drugs 2005 6 209 215 15751745
9. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. P Manilla T Rebello C Afable, Hum Gene Ther 2005 16 279 287 10.1089/hum.2005.16.17
10. A phase I/II clinical trial of {beta}-globin gene therapy for {beta}-Thalassemia. A Bank R Dorazio P Leboulch, Ann NY Acad Sci 2005 1054 308 315 10.1196/annals.1345.007 16339679
11. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1). TZ Liu CY Chen SJ Yiin CH Chen JT Cheng MK Shih YS Wang CL Chern, Food and Chemical Toxicology 2006 44 227 235 10.1016/j.fct.2005.07.003
12. The retinoblastoma protein and cell cycle control. RA Weinberg, Cell 1995 81 323 330 10.1016/0092-8674(95)90385-2 7736585
13. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. H Koga S Sakisaka M Harada T Takagi S Hanada E Taniguchi T Kawaguchi K Sasatomi R Kimura O Hashimoto T Ueno H Yano M Kojiro M Sata, Hepatology 2001 33 1087 1097 10.1053/jhep.2001.24024 11343236
14. Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. J Chang Y Hsu P Kuo Y Kuo L Chiang C Lin, Life Sci 76 16 1883 1893 10.1016/j.lfs.2004.11.003 15698865
15. Lu S-adenosylmethionine and Its Metabolite Induce Apoptosis in HepG2 Cells: Role of Protein Phosphatase 1 and Bcl-xS. H Yang MR Sadda M Li Y Zeng L Chen W Bae X Ou M T Runnegar J M Mato C Shelly, Hepatology 2004 40 1 221 231 10.1002/hep.20274 15239106
16. Inhibition of Hepatitis B virus gene expression by single and dual small interfering RNA treatment. KL Wu X Zhang J Zhang, Virus Research 2005 112 100 107 10.1016/j.virusres.2005.04.001 16022904
17. Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system. K Wu Y Mu J Hu, Antiviral Research 2007 74 142 149 10.1016/j.antiviral.2006.11.004 17173982
18. Trono, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. L Naldini U Blomer P Gallay D Ory R Mulligan FH Gage IM Verma D Trono, Science 1996 272 263 267 10.1126/science.272.5259.263 8602510
19. A third-generation lentivirus vector with a conditional packaging system. T Dull R Zufferey M Kelly RJ Mandel M Nguyen D Trono L Naldini, J Virol 1998 72 8463 8471 9765382
20. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. A Pfeifer T Kessler S Silletti DA Cheresh IM Verma, Proc Natl Acad Sci USA 2000 97 12227 12232 11035804 10.1073/pnas.220399597
21. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. L Naldini U Blomer FH Gage D Trono IM Verma, Proc Natl Acad Sci USA 1996 93 11382 11388 8876144 10.1073/pnas.93.21.11382
22. Ponicidin inhibits cell growth on hepatocellular carcinoma cells by induction of apoptosis. J-F Zhang P-Q Liu G-H Chen M-Q Lua C-J Cai Y Yanga H Li, Digestive and Liver Disease 2007 39 160 166 10.1016/j.dld.2006.09.011
23. Inhibition of cell growth and induction of G1-phase cell cycle arrest in hepatoma cells by steroid extract from Meretrix meretrix. Wua Ting-He Yang Ruo-Lin Xie Li-Ping Wang Hong-Zhong Chen Lei Zhang Shuyi Zhao Yong Zhang Rong-Qing, Cancer Letters 2006 232 199 205 10.1016/j.canlet.2005.02.018 16458116
24. Overexpression of Integrinβ1 Inhibits Proliferation of Hepatocellular Carcinoma Cell SMMC-7721 Through Preventing Skp2-Dependent Degradation of p27 via PI3K Pathway. Y Fu Z Fang Y Liang X Zhu P Prins Z Li L Wang L Sun J Jin Y Yang X Zha, Journal of Cellular Biochemistry 2007 102 704 718 10.1002/jcb.21323 17407140
25. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. MM Bradford, Anal Biochem 1976 72 248 54 10.1016/0003-2697(76)90527-3 942051
26. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. SC Lu L ALvarez ZZ Huang L Chen W An FJ Corrales MA Avila G Kanel JM Mato, Proc Natl Acad Sci USA 2001 98 5560 5565 11320206 10.1073/pnas.091016398
27. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. ML Martínez-Chantar FJ Corrales A Martínez-Cruz ER García-Trevijano ZZ Huang LX Chen G Kanel MA Avila JM Mato SC Lu, FASEB J 2002 16 10 1292 1294 12060674
28. Molecular cloning and developmental expression of a human kidney S-adenosylmethionine synthetase. S Horikawa K Tsukada, FEBS Lett 1992 312 37 41 10.1016/0014-5793(92)81405-B 1426236
29. Characterisation of a full-length cDNA encoding human liver S-adenosylmethionine synthetase. Tissue specific gene expression and mRNA levels in hepatopathies. L Alvarez F Corrales A Martín-Duce JM Mato, Biochem J 1993 293 481 486 8393662
30. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. M Kotb SH Mudd JM Mato AM Geller NM Kredich JY Chou GL Cantoni, Trends Genet 1997 13 51 52 10.1016/S0168-9525(97)01013-5 9055605
31. Immunohistochemistry analysis of rat S-adenosylmethionine synthetase isozymes in developmental liver. S Horikawa H Ozasa K Ota K Tsukada, FEBS Lett 1993 330 307 311 10.1016/0014-5793(93)80894-Z 8375501
32. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development. B Gil M Casado MA Pajares L Bosca' JM Mato P Martín-Sanz L Alvarez, Hepatology 1996 24 876 881 8855191
33. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. SC Lu L Alvarez ZZ Huang L Chen W An FJ Corrales MA Avila G Kanel JM Mato, Proc Natl Acad Sci USA 2001 98 10 5560 5565 11320206 10.1073/pnas.091016398
34. Liver Cell Proliferation Requires Methionine Adenosyltransferase 2A mRNA Up-regulation. C Paneda I Gorospe B Herrera T Nakamura I Fabregat I Varela-Nieto, Hepatology 2002 35 1381 1391 10.1053/jhep.2002.32538 12029623
35. NO sensitizes rat hepatocytes to hepatocyte growth factor-induced proliferation through the modulation of S-adenosylmethionine levels. ER García-Trevijano ML Martínez-Chantar MU Latasa JM Mato MA Avila, Gastroenterology 2002 122 1355 1363 10.1053/gast.2002.33020 11984522
36. S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. E Ansorena ER García-Trevijano ML Martínez-Chantar Z-Z Huang L Chen JM Mato M Iraburu SC Lu MA Avila, Hepatology 2002 35 274 280 10.1053/jhep.2002.30419 11826399
37. Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell Line (HepG2). AB Granado-Serrano MA Martín L Bravo L Goya S Ramos, The Journal of Nutrition 2006 136 2715 2721 17056790
38. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. C Chen YC Chang CL Liu TP Liu KJ Chang IC Guo, Endocr Relat Cancer 2007 14 2 513 529 10.1677/ERC-06-0027 17639064
39. Yoshiyuki Takei Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. H Fuke K Shiraki K Sugimoto J Tanaka T Beppu K Yoneda N Yamamoto K Ito M Masuy, Biochemical and Biophysical Research Communications 2007 363 738 744 10.1016/j.bbrc.2007.09.049
40. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. T Masaki Y Shiratori W Rengifo K Igarashi M Yamagata K Kurokohchi, Hepatology 2003 37 534 543 10.1053/jhep.2003.50112 12601350
41. p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis. Y Matsuda T Ichida, Med Mol Morphol 2006 39 169 175 10.1007/s00795-006-0339-2 17187177
42. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Y Matsuda T Ichida T Genda S Yamagiwa Y Aoyagi H Asakura, Clin Cancer Res 2003 9 3389 3396 12960127
43. Transcriptional regulation of the p21 ((WAF1/CIP1)) gene. AL Gartel AL Tyner, Exp Cell Res 1999 246 280 289 10.1006/excr.1998.4319 9925742
44. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27 (Kip1) in human colon cancer. A Sgambato C Ratto B Faraglia M Merico R Ardito G Schinzari G Romano AR Cittadini, Mol Carcinog 1999 26 172 179 10.1002/(SICI)1098-2744(199911)26:3<172::AID- MC6>3.0.CO;2-8 10559792